Health
TGA investigates Guillain-Barre Syndrome diagnoses after AstraZeneca – The Australian
The medical regulatory agency has launched an investigation after eight cases of a rare illness that can leave patients paralysed were diagnosed in Australians…
The medical regulatory agency has launched an investigation after eight cases of a rare illness that can leave patients paralysed were diagnosed in Australians after they had the AstraZeneca vaccine.
“A possible link between Guillain-Barre Syndrome (GBS) and the AstraZeneca COVID-19 vaccine remains under investigation in Australia and internationally,” the TGA said.
“As of 19 May 2021, we have received eight reports of GBS in patients vaccinated with the AstraZeneca COVID-19 vaccine.
“The TGA continues…
-
Noosa News18 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
General22 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News14 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense
-
Noosa News15 hours agoHomicide investigation underway after woman found dead in north Brisbane